⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for unresectable pancreatic adenocarcinoma

Every month we try and update this database with for unresectable pancreatic adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic CancerNCT06381154
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Endoscopic Ultr...
Fluorouracil
Irinotecan
Leucovorin
Lymph Node Biop...
Magnetic Resona...
Oxaliplatin
Pembrolizumab
Photodynamic Th...
Positron Emissi...
Questionnaire A...
Verteporfin
18 Years - Mayo Clinic
Ambulatory Measurement of Physical Activity in Pancreatic Cancer PatientsNCT03490604
Unresectable Pa...
wrist-worn acce...
Auto-questionna...
18 Years - Centre Hospitalier Universitaire Dijon
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal AdenocarcinomaNCT06398587
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Onvansertib
Gemcitabine
Nab-paclitaxel
Electrocardiogr...
Magnetic Resona...
Positron Emissi...
Biospecimen Col...
Biospecimen Col...
Computed Tomogr...
18 Years - OHSU Knight Cancer Institute
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsNCT04616534
Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI)
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNCT02498613
Advanced Malign...
Metastatic Lung...
Metastatic Lung...
Metastatic Panc...
Metastatic Trip...
Pancreatic Duct...
Stage III Breas...
Stage III Lung ...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Brea...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Brea...
Stage IIIB Lung...
Stage IIIB Lung...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Lung N...
Stage IV Lung S...
Stage IV Pancre...
Triple-Negative...
Unresectable Lu...
Unresectable Pa...
Unresectable Pa...
Unresectable Tr...
18F-Fluoromison...
Cediranib Malea...
Laboratory Biom...
Olaparib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Ambulatory Measurement of Physical Activity in Pancreatic Cancer PatientsNCT03490604
Unresectable Pa...
wrist-worn acce...
Auto-questionna...
18 Years - Centre Hospitalier Universitaire Dijon
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsNCT04616534
Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsNCT04616534
Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI)
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic CancerNCT04172532
Locally Advance...
Locally Advance...
Stage II Pancre...
Stage III Pancr...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Hypofractionate...
Magnetic Resona...
Peposertib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNCT02498613
Advanced Malign...
Metastatic Lung...
Metastatic Lung...
Metastatic Panc...
Metastatic Trip...
Pancreatic Duct...
Stage III Breas...
Stage III Lung ...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Brea...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Brea...
Stage IIIB Lung...
Stage IIIB Lung...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Lung N...
Stage IV Lung S...
Stage IV Pancre...
Triple-Negative...
Unresectable Lu...
Unresectable Pa...
Unresectable Pa...
Unresectable Tr...
18F-Fluoromison...
Cediranib Malea...
Laboratory Biom...
Olaparib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic CancerNCT06381154
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Endoscopic Ultr...
Fluorouracil
Irinotecan
Leucovorin
Lymph Node Biop...
Magnetic Resona...
Oxaliplatin
Pembrolizumab
Photodynamic Th...
Positron Emissi...
Questionnaire A...
Verteporfin
18 Years - Mayo Clinic
Ambulatory Measurement of Physical Activity in Pancreatic Cancer PatientsNCT03490604
Unresectable Pa...
wrist-worn acce...
Auto-questionna...
18 Years - Centre Hospitalier Universitaire Dijon
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal AdenocarcinomaNCT06398587
Locally Advance...
Metastatic Panc...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Onvansertib
Gemcitabine
Nab-paclitaxel
Electrocardiogr...
Magnetic Resona...
Positron Emissi...
Biospecimen Col...
Biospecimen Col...
Computed Tomogr...
18 Years - OHSU Knight Cancer Institute
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerNCT04514497
Metastatic Lung...
Metastatic Mali...
Metastatic Neur...
Metastatic Panc...
Stage III Lung ...
Stage III Pancr...
Stage IV Lung C...
Stage IV Pancre...
Unresectable Lu...
Unresectable Ma...
Unresectable Ne...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Elimusertib
Irinotecan Hydr...
Magnetic Resona...
Topotecan Hydro...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: